Merck & Co., Inc.

MRKNYSEUSD
113.75 USD
0.30 (0.27%)🟢PRE MARKET (AS OF 07:21 AM EDT)
🟢Market: OPEN
Open?$113.45
High?$113.70
Low?$112.82
Prev. Close?$113.45
Volume?2.2K
Avg. Volume?9.0M
VWAP?$113.09
Rel. Volume?0.00x
Bid / Ask
Bid?$112.90 × 200
Ask?$113.85 × 200
Spread?$0.95
Midpoint?$113.38
Valuation & Ratios
Market Cap?280.2B
Shares Out?2.5B
Float?2.4B
Float %?98.2%
P/E Ratio?31.36
P/B Ratio?6.11
EPS?$3.62
Dividend?2.94%
Ex-Dividend?N/A
News
Profile
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Employees
75.0K
Market Cap
277.5B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1949-04-20
Address
126 EAST LINCOLN AVENUE
RAHWAY, NJ 07065
Phone: 908-740-4000
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.30Adequate
Quick Ratio?1.06Adequate
Cash Ratio?0.20Low
Debt/Equity?1.07Moderate
ValuationFAIRLY VALUED
Score
67/100
P/E?
31.4PRICEY
P/B?
6.11FAIR
P/S?
4.26FAIR
P/FCF?
19.9CHEAP
EV/EBITDA?
16.9FAIR
EV/Sales?
4.93FAIR
Returns & Efficiency
ROE?
19.5%STRONG
ROA?
6.9%FAIR
Cash Flow & Enterprise
FCF?$14.1B
Enterprise Value?$324.0B
Fundamentals ratios updated end of day